Aleks Engel is a board member at Bactolife. Prior to this, they were with Revagenix Therapeutics, AFYX Therapeutics, and Novo Holdings. Aleks has also held positions at Baxter International and Pfizer.
Aleks Engel received their high school diploma from Herlufsholm Skole og Gods in Math and Science. Aleks then attended Georgia Tech for their BS in Chemical Engineering. Engel continued their education at M.I.T. for both their MS in Chemical Engineering and their Minor in Business Administration from the M.I.T. Sloan School of Management. Lastly, they completed their Ph.D. in Chemical Engineering from Massachusetts Institute of Technology. Aleks is also certified by the Board of Directors in Law from Københavns Universitet